MADISON, Wis., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Novelos Therapeutics, Inc. (OTCQX:NVLT) a biopharmaceutical company developing novel agents to detect, treat and monitor a broad spectrum of cancers, today announced that Dr. Simon Pedder, acting president and CEO of Novelos, will present at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 10:30 am EST at the Waldorf Astoria in New York City.